ProciseDx in the News ProciseDx in the News ProciseDx in the News June 13, 2023 November 10, 2022 July 16, 2021 July 21, 2020 ProciseDx Announces Acquisition by Biosynex S.A. to Transform Biologics Therapeutic Drug Monitoring in the US ProciseDx announces FDA Clearance of ProciseDx instrument and C Reactive Protein (CRP) assay ProciseDx Announces $13 Million Convertible Note Financing and Strong International Growth ProciseDx™ Secures $10.5 Million Series A Financing Round Led by Biosynex, Forms an Independent Point-Of-Care Diagnostic Company May 14, 2020 January 10, 2020 September 25, 2019 ProciseDx™ Files 510k and Prepares for EU launch of Novel Point of Care Technology ProciseDx™ Announces CE Mark for Point of Care Inflammatory Marker Assay ProciseDx™ Announces CE Mark for Point of Care Platform and Plans for Additional Financing in Q1 2020 October 3, 2023 ProciseDx Announces the First FDA-cleared Therapeutic Drug Monitoring Tests for Biologic Drugs , Humira®, Remicade®, and their Biosimilars June 18, 2024 Watch the full recording of Dr. Vande Casteele & Dr. Hale’s webinar presentation on TDM in Anti-TNF Treatment of Inflammatory Bowel Disease and view their presentations.
